GOCO
GoHealth, Inc.
NASDAQ · Financial Services · Insurance - Brokers · US
$0.31
−12.86%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 152.8M | 361.8M | 798.9M | 734.7M | 631.7M |
| Cost of Revenue | 56.0M | 96.1M | 130.6M | 159.0M | 187.7M |
| Gross Profit | 96.8M | 265.7M | 668.3M | 575.7M | 444.0M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 141.0M | 207.2M | 317.8M | 298.1M | 324.1M |
| General & Admin Expense | 89.8M | 90.8M | 82.1M | 93.1M | 116.5M |
| Selling & Marketing Expense | 51.2M | 116.4M | 235.7M | 205.0M | 207.6M |
| Other Expenses | 410.2M | 211.5M | 357.5M | 359.3M | 438.6M |
| Total Operating Expenses | 551.2M | 418.7M | 675.3M | 657.4M | 762.7M |
| Cost and Expenses | 607.2M | 514.8M | 805.9M | 816.4M | 950.3M |
| Operating Income (EBIT) | (454.4M) | (152.9M) | (7.0M) | (81.7M) | (318.7M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 102.2M | 87.3M | 72.9M | 69.5M | 57.1M |
| Net Interest Income | (102.2M) | (87.3M) | (72.9M) | (69.5M) | (57.1M) |
| Other Non-Op Income/Expense | (103.5M) | (348.1M) | 2.0M | (69.4M) | (57.0M) |
| Non-Operating Income (excl Interest) | 1.3M | 260.8M | (74.9M) | (37.0K) | (115.0K) |
| EBT (Pre-Tax Income) | (557.8M) | (501.1M) | (5.1M) | (151.1M) | (375.6M) |
| Income Tax Expense | (3.7M) | (3.3M) | 2.3M | 154.0K | 764.0K |
| Bottom Line | |||||
| Net Income | (289.9M) | (257.1M) | (2.9M) | (63.3M) | (148.7M) |
| Earnings from Cont. Ops | (554.1M) | (497.8M) | (7.3M) | (151.3M) | (376.4M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (292.9M) | (261.1M) | (6.6M) | (66.8M) | (149.6M) |
| Per Share | |||||
| Basic EPS | ($23.06) | ($20.17) | ($0.66) | ($7.19) | ($17.72) |
| Diluted EPS | ($23.06) | ($20.17) | ($0.66) | ($7.19) | ($17.72) |
| Revenue Per Share | $9.43 | $27.96 | $80.05 | $79.06 | $74.80 |
| Shares | |||||
| Basic Shares Outstanding | 16.2M | 12.9M | 10.0M | 9.3M | 8.4M |
| Diluted Shares Outstanding | 16.2M | 12.9M | 10.0M | 9.3M | 8.4M |
| Profitability Metrics | |||||
| EBITDA | (401.7M) | (333.7M) | 173.7M | 24.1M | (211.5M) |
| D&A | 53.9M | 80.1M | 105.9M | 105.7M | 107.0M |
| EBIT | (455.7M) | (413.8M) | 67.8M | (81.6M) | (318.6M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026